Clinical Trial Update: A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial comparing BL-M07D1 with T-DM1 in unresectable locally advanced or metastatic HER2-positive breast cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BL-M07D1
• T-DM1 (ado-trastuzumab emtansine)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: HER2-positive Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING